SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-19-000130
Filing Date
2019-07-30
Accepted
2019-07-30 08:13:16
Documents
3
Period of Report
2019-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand-8xkq219earnings.htm 8-K 25736
2 EX-99.1 q22019earningsreleasee.htm EX-99.1 269580
3 LOGO image1.jpg GRAPHIC 36525
  Complete submission text file 0000886163-19-000130.txt   346850
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 19983244
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences